⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6035007 | 0.83 | — | — | |
| SCHEMBL4382677 | 0.76 | — | — | |
| SCHEMBL34332 | 0.73 | — | — | |
| SCHEMBL284721 | 0.71 | — | — | |
| SCHEMBL17457457 | 0.71 | — | — | |
| SCHEMBL20876138 | 0.70 | — | — | |
| SCHEMBL9762888 | 0.70 | — | — | |
| SCHEMBL93745 | 0.64 | — | — | |
| SCHEMBL8863208 | 0.60 | — | — | |
| Sulfuric Acid SCHEMBL25385431 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3268 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117925225-A | Preparation method and application of silicon core double-layer quantum dot composite nanomaterial and fluorescent tag | 中国科学院合肥物质科学研究院 | 2024-04-26 | — | — | CN | claimed |
| CN-117771219-A | Ophthalmic drug-carrying implantation membrane and preparation method thereof | 上海世健达医疗器械科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-3965887-B1 | ANTIMICROBIAL CHITOSAN | UNIV GENEVE (CH) | 2024-02-28 | — | — | EP | claimed |
| CN-117503755-A | Medicine for treating hepatic fibrosis, application thereof and CD36 inhibitor | 南方科技大学 | 2024-02-06 | — | — | CN | claimed |
| WO-2024023289-A1 | B CELL-SPECIFIC MAB-SIRNA CONJUGATES IMPROVE MYASTHENIA | ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES (FR) | 2024-02-01 | — | — | WO | claimed |
| EP-4311579-A1 | B CELL-SPECIFIC MAB-SIRNA CONJUGATES IMPROVE MYASTHENIA | Association Française contre les Myopathies (FR) | 2024-01-31 | — | — | EP | claimed |
| CN-117462689-A | Composition for treating liver fibrosis and application thereof | 南方科技大学 | 2024-01-30 | — | — | CN | claimed |
| US-20240011011-A1 | BIOCATALYTICAL COMPOSITION | INOFEA GMBH (CH) | 2024-01-11 | — | — | US | claimed |
| CN-115590958-B | Near infrared light/enzyme procedural activation supermolecule prodrug system and preparation method | 中山大学 | 2023-12-01 | — | — | CN | claimed |
| WO-2023220678-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY (US) | 2023-11-16 | — | — | WO | claimed |
| WO-1994016741-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING HETERODIMERS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-08-04 | — | — | WO | claimed |
| WO-1994013327-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING DIHYDROFOLATE REDUCTASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-23 | — | — | WO | claimed |
| WO-1994012216-A1 | SEQUENTIAL TARGETING OF TUMOR SITES WITH OLIGONUCLEOTIDE CONJUGATES OF ANTIBODY AND COMPLEMENTARY OLIGONUCLEOTIDE CONJUGATES OF CHELATED RADIONUCLIDE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| EP-0310716-B1 | A PRODUCT, PREPARATION AND METHOD FOR TREATING ALLERGIES | IMMUNET (US) | 1993-03-10 | — | — | EP | claimed |
| WO-1992013525-A1 | SYNTHETIC MEMBRANE VESICLES CONTAINING FUNCTIONALLY ACTIVE FUSION PEPTIDES AS DRUG DELIVERY SYSTEMS | NIKA HEALTH PRODUCTS LIMITED (LI) | 1992-08-20 | — | — | WO | claimed |
| EP-0497997-A1 | Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems | NIKA HEALTH PRODUCTS LIMITED (LI) | 1992-08-12 | — | — | EP | claimed |
| EP-0396116-A2 | Covalent attachment of specific binding members to a solid phase | ABBOTT LABORATORIES (US) | 1990-11-07 | — | — | EP | claimed |
| EP-0175973-B1 | SUPPORT MATERIAL FOR THE USE IN IMMUNOASSAYS | ORPEGEN Medizinisch-Molekularbiologische Forschungsgesellschaft m.b.H (DE) | 1989-11-08 | — | — | EP | claimed |
| EP-0305128-A1 | Hair treatment process | UNILEVER PLC (GB) | 1989-03-01 | — | — | EP | claimed |
| US-4716122-A | Carrier material for use in immune determinations | ORGANOGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT M.B.H. (DE) | 1987-12-29 | — | — | US | claimed |